The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Conferences ASCO 2020: Combination therapy well-tolerated and highly effective for patients with IDH1-mutated AML June 2, 2020 A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was…